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 The glycolytic pathway has a central role in metabolism by supplying precursor, energy and redox 
molecules for supporting well-being of microorganism at natural habitat. Advent of synthetic biology, 
however, facilitates proliferation of microorganisms beyond their original niche. The native glycolytic 
pathway often contains thermodynamic bottleneck and stoichiometry limiting their wide-range 
application. Adopting alternative glycolytic structure bypassing such metabolic hurdles enables to 
expand and diversify traits of a microbial strain. Here, we completely inactivate the Embden-
Meyerhof-Parnas (EMP) pathway in Escherichia coli which functions as major glycolytic route. In 
order to surpass sub-optimality of latent alternative glycolytic routes in glucose catabolism, E. coli 
strain without the functional EMP pathway was subjected to adaptive evolution with glucose as sole 
carbon source. The evolved mutant exhibiting 6.6-fold higher growth rate was isolated. Based on 
whole genome sequencing data, key genotype changes were identified from genotype-phenotype 
relationship. Disabilities of glucose uptake and glucose catabolism sole via the Pentose-phosphate (PP) 
pathway were identified as primary metabolic bottlenecks upon complete loss of the upper EMP 
pathway. These can be resolved by simultaneous enabling of glucose uptake and activating latent the 
Entner-Doudoroff (ED) pathway for glucose catabolism. By rebalancing two alternative glycolytic 
pathways, the ED and PP pathway, tuning profile of carbon, energy and redox equivalents yield from 
glucose was demonstrated. Combining the rebalancing strategy to adaptive evolution, 3-
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 Across the domains of life the glycolytic pathway is a shared carbon feeding module catabolizing 
monosaccharaides into pyruvate and energy [1-3]. The Embden-Meyerhof-Parnas (EMP) pathway is a 
typical sequence of the glycolytic pathway [4]. Escherichia coli also metabolize a glucose via the 
EMP pathway and generate two pyruvates as well as two NADH and two ATP [5].
  
 Parallel with increasing attention on value-added chemical production in microbial cell factories, 
necessity of developing microbial host for enhanced bioconversion efficiency has raised [6]. 
Considering primary role of glycolysis in serving energy, reducing equivalents and precursors for 
synthesis of small molecules and cell skeleton, engineering to facile and versatile structure is highly 
desirable [7].  
 Despite of prevalence as glycolysis, the EMP pathway possesses two thermodynamic bottlenecks at 
fructose 6-phosphate aldolase and triose-phosphate isomerase [8]. In addition, phosphofructokinase 
catalyzing one of the committed steps in the EMP pathway is subjected to intensive regulations on 
transcription, translation, and even post-translation and allosteric level by distal metabolites such as 
PEP and citrate as well as energetic precursor such as AMP, ADP, and ATP [9]. Regeneration rate of 
redox equivalent in the EMP pathway is under the anabolic demand [10].
  
 Responding to challenges of diverse and dynamic local niches, some of microorganism have adapted 
alternative glycolytic pathway such as the Entner-Doudoroff (ED) or Pentose Phosphate (PP) 
pathway[11]. They are all distinct in terms of thermodynamic and metabolite profile [12].
 
Compared 
to the EMP pathway, the ED pathway generates one less ATP during conversion of glucose-6-
phsophate to pyruvate [12]. Thermodynamic analysis of the ED pathway showed that at the expense 
of missing one ATP generation it can carry the same metabolic flux with 3.5-fold less enzyme 
compared to the EMP pathway [8, 13]. In addition, Zymomonas mobilis exclusively relying on the ED 
pathway shows remarkably fast glucose uptake and ethanol production rate [14]. When the PP 
pathway runs as major glycolytic pathway upon absence of phosphofructokinase, it operates in 
partially cyclized manner regenerating extreme amount of NADPH. In the unique metabolic 
architecture called the partial cyclic PP pathway transketolase or transaldolase produces fructose 6-
phosphate, which is in turn converted into glucose 6-phsohate again via reverse reaction of 
phosphoglucose isomerase. Then it can enter PPP again. Upon complete recycling of fructose 6-








Figure 1. The major and alternative glycolytic pathways in Escherichia coli. (a) The central 
carbon metabolism in E. coli. The Embdem-Meyerhof-Parnas (EMP), the Pentose Phosphate (PP), 
and the Entner-Doudoroff (ED) pathway are shown in blue, orange and green, respectively. Schematic 
representation of native glycolytic flux (b) to the redirected glycolytic routes upon elimination of 





 In E. coli, it was demonstrated that disruption of the EMP pathway at the phosphofructokinase or 
phosphoglucose isomerase redirected glycolytic flux to the ED or PP pathway [16]. However, these 
mutants showed retarded glucose uptake rate and biomass accumulation during growth on glucose as 
a major carbon source due to un-optimized alternative route [16]. So far studies on physiology of 
mutants with reduced phosphofructokinase activity was reported [16-19], which was followed by 
efforts to engineer such mutants to address those issues based on the discoveries. However, limited 




engineered mutant with desirable traits [16, 20].
 
In the meanwhile, Adaptive Laboratory Evolution 
(ALE) offers a powerful tactic for isolating a desired mutant with an aid of natural selection driven by 
artificial pressure [21]. Except for acquisition of evolved mutant itself, ALE provides insights on 
metabolic landscape by redistributing fluxes or even activating latent pathway enabling metabolic 
bottleneck bypassing [22]. In fact, laboratory evolution of pfkA knock-out E. coli mutant was reported 
in literature [23]. However, the mutant evolved toward merely compensating the loss of gene by 
reinforcing expression of the minor isoform of phosphofructokinase [23].
  
 Here, we isolated pfkAB-deleted E. coli mutant which showed improved growth on glucose even 
without phosphofructokinase from ALE. Genotype changes acquired during evolution were analyzed 
by whole genome sequencing and key changes contributing to alleviating growth defect were 
identified. In addition, metabolic bottlenecks of phosphofructokinase-deficient E. coli mutant were 
discussed focusing on divergent roles of two pivotal genes at mutation hot spot, 6-phosphogluconate 
node. Finally, based on what we learned from ALE result we further engineered the evolved mutant 
suitable for production host carrying NADPH-consuming synthetic pathway and applied them to 3-






II. Materials and methods 
 
 
2.1 Bacterial strains, plasmids and general techniques 
 
 The bacterial strains and plasmids used in this study are listed in Table 1. Wild type E. coli MG1655 
strain was used as parent strains to construct mutant strains.  
For plasmid isolation, LaboPass plasmid miniprep kit (Cosmo Genentech, Korea) was used. DNA 
purification (103-102) and gel extraction kits (102-102) were purchased from GeneAll Biotechnology 
(Seoul, Korea). The primers were synthesized by Macrogen Inc. (Seoul, Korea). Unless indicated, 
chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Antibiotics were used as following concentrations: ampicillin (100 mg/ml), kanamycin (50 mg/ml) or 
chloramphenicol (30 mg/ ml). 
 
Table 1. Strains and plasmids used in this study. 
Strains/plasmids Genotype and description Source 
Strains   






rfb-50 rph-1 [24] 
ΔpfkA MG1655 ΔpfkA::FRT  [25] 
ΔpfkAB ΔpfkA ΔpfkB::FRT [25] 
Δpgi MG1655 Δpgi::FRT  [25] 
EDA50 ΔpfkAB adapted in glucose minimal media [25] 
EDA50-2 ΔpfkAB adapted in glucose minimal media [25] 
EDA50-3 ΔpfkAB adapted in glucose minimal media [25] 
EDA50-4 ΔpfkAB adapted in glucose minimal media [25] 










 (a812g) This study 
EDA50_u EDA50 (ugd-gnd-wbbL-2)
+ 
(2312bp deletion in ugd-gnd-wbbL-2 











(t740c) This study 
AB_n ΔpfkAB  ΔgntR::gntR
A141E 
(c422a) This study 
AB_l ΔpfkAB  ΔgalR::galR
G271D 
(g812a) This study 
AB_u ΔpfkAB  Δ(ugd-gnd-wbbL-2)::FRT This study 
AB_lu AB_l Δ(ugd-gnd-wbbL-2)::FRT This study 
AB_nu AB_n Δ(ugd-gnd-wbbL-2)::FRT This study 
AB_nl AB_n  ΔgalR::galR
G271D 






(g812a)  This study 
AB_nulc AB_nul Δcrp::crp
A85S 
(g253t) This study 
EDA50_Δn EDA50 ΔgntR
A141E
::FRT This study 
EDA50_n pGalP EDA50_n with pGalP This study 
EDA50_Δl EDA50 ΔgalR
G271D
::FRT This study 
EDA50_l pEdd-Eda EDA50_l with pEdd-Eda This study 
EDA50_u Δgnd EDA50_u Δgnd::FRT This study 
EDA50 pRFP EDA50 with pRFP This study 
EDA50 pGnd EDA50 with pGnd This study 
































_FRT pMCR pACC This study 
ΔpfkA fabI
ts




_FRT pMCR pACC This study 
ΔpfkAB fabI
ts











_FRT pMCR pACC This study 
EDA50 fabI
ts















 pMCR pACC 
EDA50 ΔfabI::fabI
S241F
_FRT pGnd-GntR pMCR pACC This study 
MG-LacZ40a MG ΔlacZ838-879::PP3BCD2-tetA [26] 
Plasmids   
pBbS6a-rfp SC101 ori, carrying PLlacO-1 promoter and rfp, Amp
R
 [27] 
pBbE2k-rfp ColE1 ori, carrying PtetO promoter and rfp, Kan
R
 [27] 
pBbA6c-rfp pA15 ori, carrying P LlacO-1 promoter and rfp, Cm
R
 [27] 
pGalP pBbS6a with Δrfp::galP (from MG1655), Amp
R
 This study 
pEdd-Eda pBbS6a with Δrfp::edd-eda (from MG1655), Amp
R
 This study 
pRFP pBbS5a-rfp; SC101 ori, PlacUV5 promoter and rfp, Amp
R
 [27] 
pGnd pRFP with Δrfp::gnd (from MG1655), Amp
R
 This study 
pGnd-GntR pRFP with Δrfp::gnd-gntR (from MG1655), Amp
R
 This study 
pSIM5 



















pCDF-mcrC*-mcrN pCDF-mcrC*(N391V/K557W/S565N) –mcrN [31] 
pMCR pBbE2k-mcrC*(N391V/K557W/S565N) –mcrN This study 
pBbA2k-accDABC pBbA2k-rfp with Δrfp::accD, accA, accB and accC, Km
R
 [32] 
pACC pBbA6c-rfp with Δrfp::accD, accA, accB and accC, Km
R
 This study 
 
2.2 Adaptive Laboratory evolution 
 
 In order to isolate fast-growing mutant even without the functional EMP pathway, the mutant with 
both pfkA and pfkB genes deleted was adapted by serially transfer method in previous study [25]. 
Briefly, overnight grown ∆pfkAB mutant in LB was transferred to M9 minima media (BioShop 
Canada Inc., Burlington, Canada) supplemented with 2 mM MgSO4, 0.1 mM CaCl2 and 5 g/L glucose 
and grown in 37 °C and 200 rpm. At optical density at 600 nm (OD600) around 1.0, cells were passed 
to fresh media. This procedure was repeated during 50 times. Then, 50
th
-time subultured cells were 
plated on to LB agar plate. Five evolved mutant showing the fastest biomass accumulation were 
screened by OD600 monitored by 96-well microplate reader (Infinite M200 TECAN, Austria) and 
named as EDA50, EDA50-2 to -5.  
 
2.3 Genome sequencing 
 
 Whole genome sequencing of EDA50 was conducted as mentioned before. [25] Briefly, genomic 
DNA of EDA50 was isolated by using DNA isolation kit (GeneAll Biotechnology Co., Korea). It was 
sequenced by Next Generation Sequencing using Illumintha HiSeq 2000 sequencer (Macrogen Inc., 
Korea). The genomic sequence of E. coli MG1655 (NC_000913.3) was used as reference.  
 Occurrence of mutations was confirmed by DNA sequencing of PCR amplicon of target region in the 
unevolved and evolved mutant. In order to analyze mutation frequency, for four other EDA50 mutants 
existence of either the same or equivalent to mutation discovered in EDA50 was analyzed by PCR 
amplification and DNA sequencing.  
 
2.4 Genetic manipulation 
 
 Plasmids were transformed by preparation of electrocompetent cells and electric impulse [33].
 
Over-
night grown cells were 1:100 diluted to fresh media. After grown until OD600 around 0.5, Cells were 




re-suspended with 50 µL ice-cold distilled water, approximately 100 ng of the plasmid
 
were added and 
transformed by electroporation using a MicroPulser (BioRad, Hercules, CA). Then, the electric-
shocked cells were incubated in 1 mL SOC for 3 hours and plated on to LB agar plate with 
appropriate antibiotics for selection. Cells carrying plasmid with temperature-sensitive origin were 
grown at 30 ºC for plasmid maintenance. Otherwise, cells were grown at 37 ºC.  
 To construct knock-out mutant, homologous recombination based on λ RED recombination system 
was used, which was mediated by kanamycin resistance (Km
R
) cassette flanked by FLP recognition 
target (FRT) knock-in and flippase-based curing [30]. Knock-in FRT-flanked Km
R 
cassettes were 
obtained by PCR amplification using primers designed to amplify FRT-Km
R
-FRT region from pKD13 
with 50 bp overhang homologous to targeted deletion site. All cassettes were amplified using Pfu-X 
DNA Polymerase (Solgent, Seoul, Korea). First, the helper plasmid pSIM5 carrying λ RED 
recombination system was transformed. The resulting cells were rendered to be electrocompetenet by 
the above-mentioned procedure with an addition of a step where just before being harvested cells 
were heat-shocked at 42 ºC for 15 minutes to induce the λ RED system One-step inactivation of 
chromosomal genes in Escherichia coli K-12 using PCR products [29]. After transformation of the 
knock-in cassette and selection on LB agar plate with appropriate antibiotics, correct integration was 
confirmed using colony PCR. The knocked-in Km
R 
gene was cured by transformation of flippase-
carrying pCP20. Then cells were streaked on LB agar plate with no antibiotics and grown overnight at 
42 ºC to dilute out temperature-sensitive pSIM5 and pCP20. Cells were screened for antibiotics 
sensitivity and for those without any antibiotics resistance removal of the Km
R
 gene was confirmed by 
colony PCR and sequencing.  
 For construction of single-mutation-repaired EDA50 or mutation introduced ∆pfkAB mutant, λ RED 
recombination system together with tetA cassette enabling tetracycline-based dual selection system 
was used [26].
 
tetA cassettes were prepared by PCR amplification using primers p3-BCD2-tetA region 
from MG-LacZ40a with 50 bp overhang homologous to designated insertion site. For transformation 
of the tetA cassette, cells were prepared following the procedure for transformation of Km
R
 cassette 
during gene deletion. After electric shock cells were recovered at 30 ºC. At the same temperature, 
selection was conducted in presence of chloramphenicol together with tetracycline to maintain pSIM 
for following transformation. The wild-type or mutant allele fragments replacing the inserted tetA 
cassette were prepared by PCR amplification using MG1655 or EDA50 as template with 50 bp 
overhang homologous to designated insertion site. Again, cells were transformed with replacing DNA 
fragment by the early method. After recovery, cells still possessing tetA cassette cells were ruled out 
and true transformants were enriched by the previous method with minor modification [26].
 
Briefly, 
the transformed cells were 100-fold diluted to liquid 0.5% glucose M9 medium supplemented with 2 












cells were spread onto antibiotics-free LB agar plate and grown at 42 ºC. After screened for 
antibiotics sensitivity and for those without any antibiotics resistance correct allelic replacement was 
confirmed by colony PCR and sequencing. 
 
2.5 Plasmid construction  
 
 All plasmids constructed here were derived from BioBrick plasmids [27]. To construct pBbA6c-edd-
eda, the gene encoding red fluorescent protein (RFP) in the pBbA6c-rfp vector was digestion with 
EcoRI and BamHI. The edd-eda gene cluster was amplified from E. coli MG1655 genomic DNA with 
a forward primer containing an EcoRI site and a reverse primer containing a BamHI sites. Purified 
edd-eda fragment after digested with EcoRI and BamHI was ligated with the gel-eluted pBbA6c 
backbone.    
 For cloning galP gene, the gene encoding RFP in the pBbS6k-rfp vector was digestion with BglII 
and XhoI. The E. coli galP gene was amplified from E. coli MG1655 genomic DNA with a forward 
primer containing a BglII site and a reverse primer containing a XhoI sites. Purified galP fragment 
after digested with BglII and XhoI was ligated with the gel-eluted pBbS6k backbone.  
 In order to construct pBbS5a-gnd, the gene encoding RFP in the pBbS5a-rfp vector was digestion 
with EcoRI and XhoI. The E. coli gnd gene was amplified from E. coli MG1655 genomic DNA with a 
forward primer containing an EcoRI site and a reverse primer containing XhoI sites. Purified gnd 
fragment after digested with EcoRI and XhoI was ligated with the gel-eluted pBbS6k backbone.  
 For construction of pBbS5a-gnd-gntR, the E. coli gntR gene was amplified from E. coli MG1655 
genomic DNA with a forward primer containing a BglII site and a reverse primer containing XhoI 
sites. Purified gntR fragment after digested with BglII and XhoI was ligated with the purified 
pBbS6k-gnd after digestion with BamHI and XhoI.  
 For constructing pMCR plasmid, mcrC
*
-mcrN fragment including genes encoding dissected C-
terminal domain carrying three mutation (N391V/K557W/S565N) and N-terminal domain of 
malonyl-CoA reductase from Chloroflexus aurantiacus was extracted after digesting pCDF- mcrC*-
mcrN plasmid at EcoRI and XhoI site [31]. The pBbE2k-rfp plasmid was digested with EcoRI and 
XhoI for removal of gene encoding RFP. The DNA fragment and the gel-eluted pBbE2k backbone 
were ligated.  For construction of pACC plasmid, fragment of accDABC gene cluster encoding 
acetyl-CoA acetyl-CoA carboxyltransferase (ACC) complex was obtained from elution after digesting 
pBbA2k-accDABC at BglII and XhoI site. The pBbA6c-rfp plasmid was digested with BglII and 
XhoI for removal of gene encoding RFP. After gel-elution, pBbA6c backbone was ligated with the 
eluted accDABC fragment.  




were purchased from Fermentas (Vilnius, Lithuania). Primers used for plasmid cloning were listed in 
Table 2.  
 
Table 2. Primers used in this study. 

























ugd-gnd-wbbL FP TAATCAGCATCCCGGTAGGC 



















crp-RP  ATGGCGCGCTACCAGGTAAC 
crp_seqFP ATAGCCCCTTCCCAGGTAG 

















BamHI_edaEc RP CCCGGATCCTTACAGCTTAGCGCCTTCTAC 
BglII_RBS_galPEc FP CCAGATCTAAAAATAACCATATTGGAGGGCATC 







gnd seqFP_2 GATTTGATGACCATAACCGC 
gnd seqRP_2  GTCAGTGGGAGAGATCTCAC 
EcoRI-BglII-gnd FP CCCCCCGAATTCAAAAGATCTTGATCACACCTGACAGGAGT 
XhoI-BamHI gnd RP GGGGGGCTCGAGTTTGGATCCTTAATCCAGCCATTCGGTATGG 
EcoRI_BglII gntR FP 
CCCCCCGAATTCAAAAGATCTCTGGACGGAAGTCCAGGCCATA
AACATGAAAAAGAAAAGACCCGTACTTC 



















fabI seqRP ACCTTTGCGGCTTCCGGGAC 
 
2.6 Cell culture 
 
 For growth measurement, a single colony from an agar plate was inoculated in 3 mL of LB medium 
at 37 °C at 200 rpm. Overnight-grown cells were 1:10 transferred to 4 mL of the M9 medium 
supplemented with 2 mM MgSO4, 0.1 mM CaCl2 and 5 g/L glucose with appropriate antibiotics if 
required. After grown for 9 hours, cells were inoculated into 25 mL of the M9 medium in a 250-mL 
shaking flask at 37 °C at 200 rpm to achieve an initial OD600 around 0.1. Expression of galP and edd-
eda was induced by the addition of 6.25 µM of IPTG at the beginning of both subculture and culture.  
Expressions of pRFP, pGnd and pGnd-GntR plasmids were induced by the addition of 50 µM of IPTG 
3 h after culture start. OD600 was measured on a spectrophotometer (Libra S22).  
 For 3-HP production, a single colony from an agar plate was inoculated in 3 mL of LB medium at 




g/L glucose, 1.0 g/L yeast extract, 2 mM MgSO4, 0.1 mM CaCl2 and trace elements. The composition 
of trace element solution is as follow: 2.4 g of FeCl3·6H2O, 0.3 g of CoCl2·6H2O, 0.15 g of 
CuCl2·2H2O, 0.3 g of ZnCl2, 0.3 g of Na2MO4·2H2O, 0.075 g of H3BO3, and 0.495 g of MnCl2·4H2O 
per liter [32].
 
After grown at 30 °C and 200 rpm for 9 hours, 50 µM of IPTG and 100 nM of 
tetracycline for expression of mcrC*-mcrN and accDABC. Just after inducers were added, 






 At 3-hour post-induction, Intracellular pyridine nucleotides NADP+ and NADPH were extracted and 
assayed using EnzyChrom™ NADP
+
/NADPH assay kit (BioAssay Systems, Hayward, CA, USA) 
following the manufacturer's instructions.  
 
2.8 Analytical method 
 
 Concentrations of glucose and 3-HP were measured by HPLC using the method previously 
described with slight modification [34]. After 20-fold diluted, 20 µL of samples were injected into an 
a 300 mm × 7.8 mm Aminex HPX-87H (Bio-Rad, USA) column at 35 °C using 5.41 mM H2SO4 as 
mobile phase. 
 Culture media was treated using previously reported method with minor modifications [35]. After 
centrifuging for 30 minutes at 13,200 g, the supernatant was heat-treated at 80 °C for 1 hour. Then, 









3.1 Adaptive evolution of phosphofructokinase-deficient E. coli mutant 
 
 In E. coli, there are two phosphofructokinase (PFK) isozymes, PFK-1 and PFK-II encoded by pfkA 
and pfkB, respectively [36]. In order to construct mutant without functional EMP pathway, mutant 
with both pfkA and pfkB deleted was constructed. The double knock-out mutant exhibited virtually no 
growth with glucose as sole carbon source [16] (Fig. 2). In order to enable glucose utilization as sole 
carbon source and consequent growth, the ∆pfkAB mutant was adapted for 50-time subcultured in M9 
minimal media with 5g/L glucose by sequentially transferring to fresh media at stationary phase. 
Mutant showing the fastest cell growth was isolated as denoted as EDA50. Fitness of the evolved 
mutant and the parental strain was estimated. Growth rate of the evolved mutant was significantly 
enhanced indicating that fast-growing mutant was successfully isolated from adaptive evolution 
experiment. The EDA50 exhibited 7.2-fold increased cell mass accumulation at 12-hour cultivation, 
which corresponds to 6.6-fold increased cell growth rate. Despite of discarded functional EMP 
pathway, it grew even faster than other mutants with partial blockage of the EMP pathway such as 
∆pfkA and ∆pgi mutant did (Fig 2).  
 
Figure 2. Cell growth of mutants with partial or complete disruption of the EMP with glucose as 
sole carbon source. OD600 profile of the unevolved(▲, ∆pfkAB) and evolved (●, EDA50) E. coli 
strain with the complete EMP-disruption and strains with partial EMP-disruption at 
phosphofructokinase step (◆, ∆pfkA) or phosphoglucose isomerase step (■, ∆pgi). Cells were 
aerobically grown in shaking flasks with 0.5% glucose M9 minimal media. Error bars indicates 




3.2 Identification of key genotype changes in the evolved mutant 
 
 Genome of EDA50 was sequenced and compared with the parental strain. Five mutations were 
detected in EDA50 (Table 1).  
 
Table 3. Mutations acquired by EDA50 during adaptive evolution. 
Gene Gene product   Class 






gntR gluconate repressor protein regulator C422A (3577731)
 
GCG>GAG  331 A141E 
galR galactose repressor protein regulator G812A 2976599) GGC>GAC  343 G271D 
crp cAMP response protein regulator G253T (3486120) GCA>TCA  210 A85S 
talB transaldolase B metabolic C740T (8238) GCA>GTA  317 A247V 





- gnd- 6-phosphogluconate dehydrogenase metabolic  468 
wbbL-2 interrupted rhamnosyltransferase -  - 
 
 When isolating EDA50, four other evolved mutants exhibiting comparable growth with EDA50 were 
isolated together and denoted as EDA50-2, 3, 4, and 5, respectively (Fig. 3b). To estimate occurrence 
frequencies of each mutation, their existence in other isolates was analyzed. Mutations in gntR, galR 
and ugd-gnd-wbbL-2 were detected in all EDA50 isolates while crp and talB mutations were detected 
only in one or two isolates (Fig. 3a). Then, in order to assess how significant each mutation 
contributes to improving fitness of EDA50 five mutants each carrying single mutation restoration 
were constructed and their fitness was compared with that of the original evolved mutant. Among five 
mutations, repairing each of three mutations in gntR, galR and ugd-gnd-wbbL-2 displayed noticeable 
impact on growth of the evolved mutant. The EDA50_n, EDA50_l and EDA50_u each carrying 
single restoration of gntR, galR and ugd-gnd-wbbL-2 mutation decreased 1.8-, 1.4-, and 1.3-fold 
decreased growth rate compared to EDA50, respectively. In contrast, repair of either crp and talB 
gene had minor and no effect (Fig. 3c). Both mutation frequency and repair analysis suggest that 
among identified mutations those in gntR, galR and ugd-gnd-wbbL-2 would likely be responsible for 
enhanced cell growth with glucose as sole carbon source. To confirm that introduction of part or all 
three mutations can reproduce the growth phenotype of EDA50, the unevolved mutants with 
introduction of single or combination of those three candidates were constructed and their growth 
were compared with that of the original unevolved and the evolved mutant. The synergistic effect of 
those mutations on promoting cell growth of unevolved mutant was noticeable. When each of three 
mutations was introduced alone cell growth of resulting mutants was far below that of evolved mutant. 




the original mutant possibly due to loss of major glycolytic step. Both gntR and galR mutation 
introduced mutant, AB_n and AB_l, resulted in 2-fold increase in growth rate which corresponds to 
only 33% of that of evolved mutant. In contrast, AB_nlu possessing all those three mutations 
exhibited growth rate recovered up to 83% of that of EDA50 (Fig. 3d). Enhanced growth 
differentiating EDA50 from the unevolved mutant was attributed to occurrence of key mutations in 
gntR, galR and ugd-gnd-wbbL-2 but also their synergetic encounter.   
 
 
Figure 3. Identification of key genotype changes in EDA50. (a) The frequencies of mutations and 
(b) growth rate of the original and 5 evolved ∆pfkAB strains. (c) Effect of repairing each mutation in 
EDA50 on its growth rate. (d) Effect of introducing mutations discovered in the EDA50 to the 
unevolved strain with single or combinatorial manner. Cells were aerobically grown in shaking flasks 






3.3 Verification of real influential enzymes associated with key mutations. 
 
 In fact two key mutations in gntR and galR gene can affect expression of dozens of protein products 
because they encode transcription factors. Their positive effect on fitness observed the repair and 
reconstruction experiment might come from second-hand expression changes of such proteins rather 
from transcription factor itself.
 
We tried to figure out expression change of which genes actually play 
for the phenotype change of the evolved mutant.  
 GntR represses expression of gluconate utilizing machinery when proper substrate feed is absent 
[37]. It also controls key genes of the ED pathway, edd and eda. It is because gluconate is converted 
into 6PG then metabolized via the ED pathway to give G3P and PYR (Fig. 4a). In EDA50, glucose 
metabolisms via the EMP and PP pathway were blocked due to absence of pfkA, pfkB and gnd gene 





Therefore, we hypothesized that loss-of-function mutation in gntR gene renders 
the originally latent genes of the ED pathway de-repressed providing alternative route for glucose 
metabolism in EDA50.  
 E. coli mainly uptakes external glucose through PEP-dependent phosphotransferase system (PTS), 
which consists of enzyme I, HPr and glucose-specific EII complexes [39]. Upon disruption at upper 
glycolysis such as pfkA or pgi ptsG mRNAs stability is lowered and consequently PtsG expression 
level is decreased [19].
 
PtsG protein is a membrane receptor components of glucose-specific EII 
transporter complex of PTS [39]. Loss of PtsG resulted in retarded cell growth and slow glucose 
uptake rate due to limited capacity of glucose import [40].
 
Non-PTS glucose transporter such as GalP 
recovered glucose uptake rate in ptsG null mutant [40]. We expected that PtsG activity of the 
unevolved mutant is low due to destabilization of ptsG transcripts. GalR is a regulator which down-
regulates genes for galactose metabolism
 
when galactose is not available [41].
 
Regulon of GalR 
includes galP gene encoding galactose permease, which also shows activity to glucose [42]. Based on 
this we made a hypothesis that derepression of GalP gene due to mutated galR inactivating its product 
serves glucose transport instead of PtsG in EDA50 (Fig. 4b). 
 To prove our hypothesis, first we deleted mutant gntR and galR gene in EDA50 and denoted it as 
EDA50_∆n and EDA50_∆l, respectively. Deletion of gntR or galR gene had no effect on growth of 
EDA50 while restoration of these mutations resulted in notable negative effect on fitness of EDA50 
(Fig. 4c). This result implies that even when their inducers are unavailable mutant GntR and GalR are 
unable to bind their target site and genes in their regulons are expressed. Then we expressed 
endogenous edd-eda and galP gene in gntR- and galR-repaired EDA50, respectively. As expected, 
expression of edd-eda and galP genes can functionally replace gntR and galR mutation in EDA50 




 Other key mutation of large deletion covers two structural genes ugd and gnd. In order to verify true 
contributor for promoting fitness of EDA50, we deleted either of genes in EDA50_u which is EDA50 
strain with deleted region of ugd-gnd-wbbL-2 restored. Deletion of gnd gene in EDA50_u alone 
almost completely alleviated growth defect caused by loss of ugd-gnd-wbbL-2 mutation (Fig. 4c).  
 Together with loss of Gnd activity, binding failure of mutant GntR and GalR to their target site de-
repressed their regulons and among a number of regulated genes increase in expression of edd-eda 
and galP gene actually functions to facilitate growth of phosphofructokinase-deficient mutant. It is 
notable that two mutated genes edd-eda and gnd lie at 6PG node (Fig. 1). Interestingly, although both 
can support for alternative glycolysis complementing the interrupted EMP pathway early results 
showed that impacts of their expression on growth of EDA50 are in contrast: loss of gnd and gain of 
edd-eda expression for well-being. We investigated on how and what differentiates them regarding 
carrying out glucose catabolism. 
 
 
Figure 4. Figuring out true contributing proteins among proteins related with key genotype 
changes. (a) Description of gnd as a key gene of the oxidative PP pathway and GntR regulating key 
genes of the ED pathway, edd-eda. (b) Decription of major glucose import through 
phosphoenolpyruvate:phosphotransferase system (PTS) and GalR regulating PTS-independent 
glucose transport via glucose mease encoded by galP. (c) Growth rate of EDA50 with single mutation 
repair and corresponding compensation. Cells were aerobically grown in shaking flasks with 0.5% 
glucose M9 minimal media. 6.25 µM of IPTG was added at the beginning of both subculture and 
culture to induce each plasmid. Error bars indicates standard deviations of three independent 




3.4 Opposing effect of activating the ED and PP pathway on fitness and redox 
regeneration. 
 
 We traced back how the operation of the PP and ED pathway affects physiology of the evolved 
mutant. While the 50
th
-day isolated evolved mutant employs only the ED pathway for glycolysis, the 
PP as well as ED pathway became available for catabolizing glucose in EDA50 carrying pGnd (Fig. 
5a, b). When EDA50 harboring pGnd-GntR, its glycolysis mostly would rely on the PP pathway (Fig. 




Figure 5. Effect of restoring the PP pathway and further inactivating the ED pathway. 
Decription of avilable glycolytic routes in (a) EDA50 pRFP, (b) EDA50 pGnd and (c) EDA50 pGnd-
GntR strain. Effect of redirecting glycolytic flux from the ED pathway to the PP pathway in the 
evolved EDA50 strain on (d) growth rate and (e) [NADPH]/[NADP
+
] ratio. Cells were aerobically 
grown in shaking flasks with 0.5% glucose M9 minimal media. 50 µM of IPTG was induced at 3-hour 
cultivation to induce each plasmid. The intracellular NADP(H) concentration was estimated 3-hour 





 We first investigated the effect of availability of the ED and the PP pathway on the fitness of EDA50. 
Enabling operation of the PP pathway had an adverse effect on cell growth of EDA50 both in the 
presence and absence of the ED pathway. Expression of Gnd in EDA50 led to 1.55-fold decrease in 
growth rate of EDA50. Further blockage of the ED pathway resulted in more severe growth defect 
resulting 1.95-fold reduction in cell growth compared to red fluorescence protein expressing EDA50 
(Fig. 3c  and Fig. 5d).  
 In addition, consequences of 6PG metabolized through the ED or the PP pathway are apparently 
different in terms of NADPH regeneration. The conversion via the key enzyme of the PP pathway 
results in one NADPH regeneration while that via the key enzymes of ED pathway doesn’t. (Fig. 5a-c) 
Therefore, the intracellular redox availability would be likely to depend on structure of the glycolytic 
pathways. To see this, [NADPH]/[NADP
+
] ratios of EDA50 mutants with different glycolytic pathway 
structures were estimated. Recovering the PP pathway and additional suppressing the ED pathway 
increased [NADPH]/[NADP
+
] ratio compared to when exclusively relying on the ED pathway. The 
[NADPH]/[NADP
+
] ratio of EDA50 pGnd and EDA50 pGnd-GntR were 1.15- and 1.25-fold higher 
than that of EDA50 pRFP, respectively (Fig. 5e).  
 
3.5 Rebalancing the ED and PP pathway for biotechnology application. 
 
 Microbial production of value-added chemicals often requires supply of reducing powers in the form 
of NADPH. Studies on metabolic production of chemicals showed that the production performances 
were often confined by insufficient NADPH availability [43]. Therefore, improving NADPH 
availability is desirable for enhanced productivity and yield of such chemicals [43]. That is, the 
optimal architectures of core metabolism to sustain normal growth and metabolic over-production are 
not alike. For successful employment of the evolved mutant to biorefinery, redesign of the metabolic 
core would be required. For proof of this concept, we introduced machineries for 3-hydroxypropionic 
acid (3-HP) production to the evolved mutant, EDA50. 3-HP is a platform chemical whose bi-
functionality allows it to be further transformed into a variety of high value compounds [44]. From 1 
mol of glucose 2 mol of 3-HP can be theoretically produced with consumption of 4 mol of NADPH 
(Fig. 6a). Its redox equivalent demand is far beyond endogenous catabolic supply considering glucose 
catabolism via the EMP pathway or the linear PP pathway regenerates 1 or 2 mol of NADPH per mol 
of glucose [12]. According to stoichiometry of the ED and cyclic PP pathway restoration of the cyclic 
PP and blockage of the ED pathway might give better 3-HP production result [15]. The permanent 
obstruction of the ED pathway, however, was unsuccessful to increase co-production of hydrogen and 
ethanol slowing down cell growth [23].
 
To address this issue, we demonstrate conditional flux control 
toward the ED and PP pathway at 6PG node for improved production of 3-HP. 




availability. Efficient microbial productions of chemicals using malonyl-CoA as precursor such as 
flavonoids and fatty acids were often confined by low its intracellular concentration [45]. Here, 
acetyl-CoA carboxylase (ACC) was overexpressed to increase its supply while site-directed mutation 
rendering endogenous enoyl-[acyl-carrier-protein] reductase to be temperature-sensitive was 
introduced to reduce consumption by fatty acid synthesis [46] (Fig. 6a). 
 
 
Figure 6. Rebalancing of the ED and PP pathway and 3-HP production. (a) Description of 
engineering for efficient production of 3-HP. Heterologous 3-HP synthetic pathway was introduce by 
expressing dissected form of malonyl-CoA reductase mutant originated from C. aurantiacus. For 
malonyl-CoA accumulation, ACC was overexpressed while fatty acid synthesis was reduced. (b) 3-HP 
production titer at 48-hour post-induction. 50 µM IPTG and 100 nM tetracycline were added 9-hour 
after culture start to induce plasmids. Error bars indicates standard deviations of three and two 
independent biological replicates 
 
 As expected, mere introduction of 3-HP producing machineries to the evolved mutant didn’t result in 
significant improvement of production compared to the unevolved mutant. At 48-hour post induction, 
the unmodified EDA50-based strain produced 1.34 g/L of 3-HP while the unevolved-based one 
produced 0.83 g/L of 3-HP. Although the adapted mutant produced 1.6-fold higher 3-HP titer than the 
unevolved one when equipped equally, the fold-increase was subtle considering there was huge 
difference in biomass accumulation between them (Fig. 2 and Fig. 6b).  
 In order to achieve conditional flux rebalancing toward the ED and PP pathway, E. coli gnd and gntR 
genes are cloned under IPTG-inducible promoter and each resulting pGnd and pGnd-GntR plasmid 




so that the subsequent metabolic rearrangement didn’t affect cell fitness significantly. Induction of 
flux redistribution to the ED and PP pathway led to considerable enhancement in 3-HP titer at 48-hour 
post-induction. The 3-HP producing EDA50 mutant harboring pGnd produced 1.99 g/L of 3-HP. 
Furthermore, when the ED pathway was repressed by additional expression of its down-regulator 2.65 
g/L of 3-HP was produced from the evolved mutant, which is 3.2 times higher than that of the 
unevolved mutant furnished with the same 3-HP synthesis machinery (Fig. 6b). It indicates that not 
only the enabling glucose catabolism via the PP pathway but blockage of flux deviating to the ED 







 IV. Discussion 
 
 
 In this work, we describe engineering of E. coli mutant employing alternative glycolytic routes with 
an aid of adaptive laboratory evolution to overcome metabolic sub-optimality upon glycolytic swap. 
We subjected the E. coli mutant without the EMP pathway to serial transfer in glucose minimal media. 
After the evolved mutant was isolated, reverse and forward engineering based on whole-genome 
sequencing identified key genotype changes alleviating metabolic obstacles hampering use of 
alternative glycolysis. Focusing on opposing direction of evolution for two alternative glycolytic 
pathways, the effect of varying their activity on physiology of the evolved mutant and 3-HP 
production availability was analyzed. 
 Glycolytic swap accompanies extensive changes in energy and redox status as well as availability of 
glycolytic intermediates including key signal molecules [47]. Such complexity hampers rational 
approaches to resolve metabolic sub-optimality by requiring simultaneous and cumulative activity 
change of multiple proteins rather single protein. Here, in E. coli we discovered synergetic role of 
enabling galP and edd-eda expression and deletion of gnd gene for well-functioning E. coli mutant 
without the functional EMP pathway from analysis of the adapted mutant. It is expected that there are 
two metabolic bottlenecks in mutant which lacks of phosphofructokinase: inability to import glucose 
and use of the sole PP pathway for glucose catabolism. Thus, concurrent enabling of brining in 
glucose with its catabolism by providing both alternative glucose transporter and catabolic pathway 
are essential to alleviate them.   
 Dating back to the middle of adaptive evolution, there must have been period when the PP and ED 
pathway coexisted because to possess of at least one glycolytic route loss of the PP pathway must 
have not occurred until awakening of the latent ED pathway. Then, why did the PP pathway have to 
vanish instead of to remain for serving glycolytic flux together with the ED pathway? It was 
suggested that one of the reasons the E. coli pgi knock-out mutant relying solely on the PP pathway 
for glucose catabolism showed reduced glucose uptake rate was due to inability to oxidize excess 
NADPH regenerated from the PP pathway [48].
 
When metabolized via the ED pathway one less 
NADPH is regenerated than via the PP pathway in this mutant [49]. Compared to pgi null mutant, the 
PP pathway of pfkAB knock-out mutant is able to regenerate NADPH even more intensively due to its 
cyclized architecture [15] (Fig. 1a). Considering this, impact of dragging flux to the ED pathway on 
reduction of regeneration of NADPH would be more significant in the later mutant. Despite of partial 
relief by the ED pathway the regeneration of NADPH via the cyclized PP pathway exceeds oxidation 
rate during normal growth. Excessive NADPH can mediate flux changes of NADPH-producing 
reactions [50]. Especially, in ∆pfkAB strain the glucose 6-phosphate dehydrogenase (G6PDH) is 




Therefore, overall glycolytic rate can be retarded by high [NADPH]/[NADP
+
] ratio. In addition, the 
ED pathway is thermodynamically more feasible even than native glycolytic route, the EMP pathway, 
is [8, 13].
 
The thermodynamic favorable property enables the ED pathway to sustain the equivalent 
glycolytic flux to the EMP pathway with several folds-less amount of enzymes [8, 13].
 
In fact, Z. 
mobilis employing the ED pathway for glycolysis uptakes glucose remarkably fast [14]. This reflects 
that the capacity and turnover rate of the ED pathway would be substantial as it is called catabolic 
highway [52, 53]. Considering all, rendering the ED pathway to become sole glycolytic route rather to 
share flux with the PP pathway would benefit the phosphofructokinase deficient mutant in term of 
both reducing NADPH and expanding glycolytic capacity during selection.  
Although the metabolic transition from the PP to ED pathway partially alleviated extreme NADPH 
regeneration from the cyclized PP pathway, glycolysis via the sole ED pathway also produces one 
more NADPH compared to that of the EMP pathway [12]. Indeed, several native strains adopting the 
ED or PP pathway share loose cofactor specificity of oxidoreductases as strategy to avoid 
overproduction of NADPH [10]. Especially, G6PDHs from such strains exhibit subsequent activity 
with NAD
+
 compared to that from E. coli which is strictly NADP
+
-specific [10, 54-56]. Introducing 
NAD
+
-dependent G6PDH and controlling its activity in response to anabolic NADPH demand would 
meet different requirement of NADPH during growth and bio-synthesis phase. 
It was suggested that in the ∆pfkAB strain the glucose transport has been unable due to post-
transcriptional inhibition of major glucose transport via PTS [19]. Although PTS-independent glucose 
transporter enabled glucose import, the loss of PtsG protein would complicate the physiology of the 
EMP-disrupted strains due to large-scale change in transcriptome. Absence of PtsG activates 
adenylcyclase and cAMP level would be abnormally increased when glucose is available [57]. 
Mediated by cAMP-binding protein CRP affecting transcription of over 400 genes, the global gene 
expression pattern would be totally changed [58]. Such complexity could be resolved by restoring the 
expression of PtsG by removing of regulatory RNA binding site in 5’-UTR region of ptsG gene [59]. 
In the meanwhile, another possible reason for reduced capacity of glucose uptake in the EMP-
disrupted strains could be low availability of PEP which is essential for PTS-dependent glucose 
uptake. Previous studies showed that the ∆pfkA mutant has reduced PEP concentration [16]. In 
addition, increase in flux through the ED pathway can further lower intracellular PEP pool [18]. It is 
supported by the stoichiometry the ED pathway where PEP generation per glucose is half of that of 
the PP or EMP pathway [12]. Limited glucose importing capacity due to low PEP availability can be 
redeemed by expression PEP-independent glucose permease and if necessary, glucose kinase [40]. 
Considering all, in order to enable glucose transport with side effects minimized it is highly 
recommended to restore the disabled glucose PTS and to supplement limited capacity by expressing 







 This study describes physiology and engineering of E. coli strain utilizing alternative form of 
glycolysis. From genotype-phenotype relationship of the evolved strain, it was suggested that the 
simultaneous enabling of glucose import and glycolytic transition from the PP to ED pathway was 
critical in mitigating arrested growth of strain deficient of the functional EMP pathway. In addition, 
the divergent role of the ED and PP pathway in fitness and NADPH regeneration capacity was 
addressed. Focusing on trade-off between fitness and NADPH regeneration while activating the ED 
pathway, the conditional rebalancing of the ED and PP pathway was introduced to adjust NADPH 
regeneration capacity without sacrificing cell growth. Finally, based on the results presented here and 
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